ENVA vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
With a Piotroski F-Score of 4/9 (Stable) and a current price of $166.65 positioned between the Graham Number ($124.67) and a high Intrinsic Value ($362.26), ENVA presents a strong value-growth opportunity. The company demonstrates exceptional fundamental momentum with YoY earnings growth of 28.6% and a highly attractive forward P/E of 8.67. While insider sentiment is bearish and technical trends are currently weak, the high ROE (25.13%) and a long track record of earnings beats provide a significant safety margin. The high debt-to-equity ratio is typical for the credit services industry and is mitigated by an exceptionally strong current ratio of 22.71.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
ENVA vs JPM: Head-to-Head Comparison
This page compares Enova International, Inc. (ENVA) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.